YAP/TAZ regulates the insulin signaling via IRS1/2 in endometrial cancer.
Insulin resistance (IR) is an important mechanism of pathogenesis of endometrial cancer (EC) and explains the pathogenic mechanism of high risk factors including Obesity BMI (body mass index), Type 2 Diabetes Mellitus, PCOS and so on. Relieving IR or inhibiting the function of insulin could be one of the potential therapeutic strategies for EC, which is a PI3K-driven disease. PI3K/Akt are the central mediators for insulin/IGF1 signaling, however, the involvement of HIPPO pathway co-activators, YAP and TAZ, in insulin resistance remains to be elucidated. In the present study, we analyzed the clinical and biological data of EC patients from TCGA and observed a correlation between insulin resistance and EC. By comparing the expression level of IRS1/2 in obese vs non-obese patients, we found that the most important insulin resistance relative (IRR) genes are the contributing factors to IR. Interestingly, IRS1/2 was correlated positively with YAP/TAZ in EC patients. Knockdown of YAP/TAZ by specific siRNA inhibited the phosphorylation of IRS1 while increased the phosphorylation of IGFR1, the inhibitor of insulin signaling. Treating EC with siYAP/TAZ, YAP inhibitor Verteporfin or metformin alone only partially inhibited the function of insulin and IGF1. However, combination of siYAP/TAZ with metformin could completely inhibit the effects of insulin. Thus, our study demonstrated a novel function of YAP and TAZ in the insulin resistance via IRS1/2 in endometrial cancer. Our study also provided the rationale for the potential therapeutic treatment of EC with the combination of inhibiting YAP/TAZ and metformin.
Department of Obstetrics and Gynecology, Obstetrics and Gynecology Hospital, Fudan UniversityShanghai 200011, China; Department of Systems Biology, The University of Texas MD Anderson Cancer CenterHouston 77030, TX, USA.
Chao
C
Wang
Department of Systems Biology, The University of Texas MD Anderson Cancer Center Houston 77030, TX, USA.
Kangjin
K
Jeong
Department of Obstetrics and Gynecology, Obstetrics and Gynecology Hospital, Fudan University Shanghai 200011, China.
Hongyuan
H
Jiang
Department of Systems Biology, The University of Texas MD Anderson Cancer Center Houston 77030, TX, USA.
Wei
W
Guo
Department of Obstetrics and Gynecology, Obstetrics and Gynecology Hospital, Fudan University Shanghai 200011, China.
Chao
C
Gu
Department of Systems Biology, The University of Texas MD Anderson Cancer Center Houston 77030, TX, USA.
Yiling
Y
Lu
Department of Systems Biology, The University of Texas MD Anderson Cancer Center Houston 77030, TX, USA.
Jiyong
J
Liang
IRS1/2; YAP/TAZ; endometrial cancer; insulin signaling